natgillin/translations-raw huggingface dataset:
Hvert 3 ml hætteglas indeholder eribulinmesilat svarende til 1,32 mg eribulin.
Each 3 ml vial contains eribulin mesilate equivalent to 1.32 mg eribulin
Hvert 4 ml hætteglas indeholder 4 mg topotecan (som hydrochlorid).
Each 4 ml vial of concentrate contains 4 mg topotecan (as hydrochloride).
Hvert 4 ml hætteglas indeholder 80 mg tocilizumab (20 mg/ml).
Each 4 ml vial contains 80 mg tocilizumab (20 mg/ml).
Hvert 400 mg hætteglas bør rekonstitueres med 20 ml sterilt vand til injektionsvæsker til engangsbrug, så der opnås en 20 mg/ml opløsning.
Each 400 mg vial should be reconstituted with 20 mL of single-use sterile water for injections to yield a 20 mg/mL solution.
Hvert 5 ml flerdosishætteglas indeholder 15 mg topotecan.
Each 5 ml multi dose vial contains 15 mg of topotecan.
Hvert 5 ml hætteglas indeholder 50 mg brivaracetam.
Each 5 ml vial contains 50 mg brivaracetam
Hvert 5 ml hætteglas indeholder 50 mg cytarabin.
Each 5 ml vial contains 50 mg cytarabine
Hvert 5 ml hætteglas indeholder 8 mg natrium.
Each 5 ml vial contains 8 mg sodium.
Hvert 5 ml hætteglas med VELCADE rekonstitueres med 1 ml natriumchlorid 9 mg/ml (0,9 %) injektionsvæske, opløsning.
Each 5 ml vial of VELCADE must be reconstituted with 1 ml of sodium chloride 9 mg/ml (0.9%) solution for injection.
Hvert 5 ml-hætteglas indeholder 50 mg cytarabin (10 mg/ml).
Each 5 ml vial contains 50 mg cytarabine.
Hvert 50 mg/hætteglas rekonstitueres ved tilsætning af 5 ml sterilt vand til injektion.
To each 50 mg/vial, reconstitute by adding 5 mL of sterile water for injection.
Hvert 50 ml hætteglas indeholder 85 mg natrium.
Each 50 ml vial contains approximately 85 mg sodium.
Hvert 50 µg hætteglas indeholder et over- skud for at sikre, at der kan indgives 50 µg tilmanocept.
Each 50 microgram vial contains an additional overfill to ensure that 50 micrograms of tilmanocept can be delivered.
Hvert 80 mg hætteglas indeholder 0,10 mmol (2,21 mg) natrium.
Each 80 mg vial contains 0.10 mmol (2.21 mg) sodium.
Hvert af disse aktive stoffer virker ved at påvirke et enzym, som kaldes ”revers transcriptase”, der er vigtigt for, at hiv 1-virus kan formere sig.
Each of these active substances works by interfering with an enzyme called ‘reverse transcriptase’, which is essential for the HIV-1 virus to multiply.
Hvert af disse aktive stoffer, der også kaldes antiretroviral medicin, virker ved at påvirke et enzym (et protein, der kaldes ‘revers transkriptase’), der er essentielt for, at virus kan mangfoldiggøres.
Each of these active substances, also known as antiretroviral medicines, works by interfering with an enzyme (a protein called ‘reverse transcriptase’) that is essential for the virus to multiply.
Hvert behandlingsforløb adskilles af 2 ugers pause i behandlingen.
Each cycle of treatment is separated by a 2 week treatment-free interval.
Hvert BIO-SET hætteglas indeholder 30 mikrogram (IE) interferon beta-1a.
Each BIO-SET vial contains 30 micrograms (6 million IU) of interferon beta-1a.
Hvert blisterhul indeholder 2 tabletter.
Two tablets are contained in each blister cavity.
Hvert blisterkort indeholder 6 tabletter.
Each blister contains 6 tablets.
Hvert blisterkort indeholder 7 tabletter.
Each blister contains 7 tablets.
Hvert blisterkort indeholder 7 x 1 filmovertrukne tabletter og er pakket i en foliepose sammen med en pose tørremiddel.
Each blister contains 7 x 1 film-coated tablets and is packed together with a desiccant sachet in an aluminium pouch.
Hvert brev af 2,4 g pulver skal opløses i 60 ml vand inden indgivelse.
Each sachet of 2.4 g of powder is to be dispersed in 60 ml of water prior to administration.
Hvert brev enterogranulat indeholder 4 g para-aminosalicylsyre.
Each sachet of gastroresistant granules contains 4 g of para-aminosalicylic acid.
Hvert brev indeholder 1.000 mg ataluren.
Each sachet contains 1,000 mg ataluren.
Hvert brev indeholder 1000 mg ataluren
Each sachet contains 1,000 mg of ataluren
Hvert brev indeholder 12,5 mg imiquimod i 250 mg creme (5 %).
Each sachet contains 12.5 mg of imiquimod in 250 mg cream (5 %).
Hvert brev indeholder 125 mg ataluren.
Each sachet contains 125 mg ataluren.
Hvert brev indeholder 2 g colestilan.
Each sachet contains 2 g colestilan.
Hvert brev indeholder 2,4 g sevelamercarbonat.
Each sachet contains 2.4g of sevelamer carbonate.
Hvert brev indeholder 250 mg ataluren.
Each sachet contains 250 mg ataluren.
Hvert brev indeholder 3 g colestilan.
Each sachet contains 3 g colestilan.
Hvert brev indeholder et depotplaster.
One sachet contains one transdermal patch.
Hvert brev indeholder et SANCUSO depotplaster, sat på en stiv plasticfilm.
Each sachet contains one SANCUSO transdermal patch stuck onto a rigid plastic film .
Hvert brev med 2,4 g pulver til oral suspension skal opløses i 60 ml vand.
The 2.4 g powder for oral suspension should be dispersed in 60 ml of water per sachet.
Hvert brev med Aldara 5% creme indeholder 250 mg hvid til let gullig creme.
Each Aldara 5% cream sachet contains 250 mg of a white to slightly yellow cream.
Hvert brev med granulat skal blandes med 5 ml alderssvarende mosede fødevarer eller 5 ml væske og skal indtages fuldstændigt straks derefter.
Each sachet of granules should be mixed with 5 mL of age-appropriate soft food or liquid and completely and immediately consumed.
Hvert brev med Sevelamer carbonate Zentiva indeholder 2,4 g sevelamercarbonat.
Each sachet contains 2.4 g of sevelamer carbonate.
Hvert brev Modigraf 0,2 mg granulat indeholder 0,2 mg tacrolimus (som monohydrat).
Each sachet of Modigraf 0.2 mg granules contains 0.2 mg of tacrolimus (as monohydrate).
Hvert brev på 1,5 g oralt pulver indeholder 50 mg atazanavir (som sulfat).
Each sachet of 1.5 g oral powder contains 50 mg of atazanavir (as sulphate).
Hvert brev Zyclara 3,75 % creme indeholder 250 mg hvid til let gullig creme med et ensartet udseende.
Each Zyclara 3.75% cream sachet contains 250 mg of a white to slightly yellow cream with a uniform appearance.
Hvert cylinderampul indeholder 3 ml injektionsvæske, opløsning svarende til 300 enheder.
Each cartridge contains 3 ml of solution for injection, equivalent to 300 units.
Hvert depotplaster er et tyndt plaster, som består af tre lag.
Each transdermal patch is a thin patch consisting of three layers.
Hvert depotplaster ligger i sit eget brev, som beskytter det, indtil du er klar til at sætte det på.
Each patch is sealed in a pouch that protects it until you are ready to put it on.
Hvert depotplaster ligger i sit eget brev, som beskytter det, indtil du er klar til at sætte det på.
Each patch is sealed in a sachet that protects it until you are ready to put it on.
Hvert depotplaster på 10 cm2 indeholder 18 mg rivastigmin.
Each transdermal patch of 10 cm2 contains 18 mg of rivastigmine.
Hvert depotplaster på 15 cm2 indeholder 27 mg rivastigmin.
Each transdermal patch of 15 cm2 contains 27 mg of rivastigmine.
Hvert depotplaster på 5 cm2 indeholder 9 mg rivastigmin.
Each transdermal patch of 5 cm2 contains 9 mg of rivastigmine.
Hvert Docetaxel Teva koncentrat indeholder 80 mg/2.88 ml docetaxel (vandfri).
Each vial of Docetaxel Teva 80 mg/2.88 ml concentrate contains 80 mg docetaxel (anhydrous).
Hvert Empliciti-hætteglas rekonstitueres aseptisk med en sprøjte af passende størrelse og en 18 gauge kanyle eller mindre som vist i tabel 7.
Aseptically reconstitute each Empliciti vial with a syringe of adequate size and an 18 gauge or smaller needle as shown in Table 7.
Hvert engangshætteglas indeholder enten 100 mg panitumumab i 5 ml eller 400 mg panitumumab i 20 ml.
Each single-use vial contains either 100 mg of panitumumab in 5 mL, or 400 mg of panitumumab in 20 mL.
Hvert engangshætteglas med Pixuvri indeholder pixantrondimaleat svarende til 29 mg pixantron.
Each single-use vial of Pixuvri contains pixantrone dimaleate equivalent to 29 mg pixantrone.
Hvert engangshætteglas med pulver indeholder 500 enheder C1-hæmmer (human) fremstillet af plasma fra humane donorer.
Each single-use powder vial contains 500 Units of C1 inhibitor (human) produced from the plasma of human donors.
Hvert enkeldosis-hætteglas med Docetaxel Teva Pharma koncentrat indeholder 20 mg docetaxel (vandfri).
Each single-dose vial of Docetaxel Teva Pharma concentrate contains 20 mg docetaxel (anhydrous).
Hvert enkelt hætteglas er til engangsbrug.
Each vial is for single–use only.
Hvert enkelt hætteglas med pulver til injektionsvæske, opløsning, indeholder 150 mg secukinumab.
Each vial of powder for solution for injection contains 150 mg secukinumab.
Hvert enkelt hætteglas til engangsbrug er pakket i en papkarton.
Each single-use vial is packaged in a cardboard carton.
Hvert enkeltdosis-hætteglas indeholder 20 mg docetaxel (vandfri).
Each single-dose vial of powder contains 20 mg docetaxel (anhydrous).
Hvert enkeltdosis-hætteglas med pulver indeholder 20 mg docetaxel (vandfri).
Each single-dose vial of powder contains 20 mg docetaxel (anhydrous).
Hvert enkeltdosis-hætteglas med pulver indeholder 80 mg docetaxel (vandfri).
Each single-dose vial of powder contains 80 mg docetaxel (anhydrous).
Hvert flerdosis hætteglas indeholder 33 mikrogram follitropin alfa* (svarende til 450 IE), så der kan dispenseres 22 mikrogram (svarende til 300 IE) i 0,50 ml .
Each multidose vial contains 33 micrograms of follitropin alfa* (equivalent to 450 IU), in order to deliver 22 micrograms (equivalent to 300 IU) in 0.50 mL.
Hvert flerdosis hætteglas indeholder 33 mikrogram follitropin alfa, svarende til 450 IE.
Each multidose vial contains 33 micrograms follitropin alfa equivalent to 450 IU.
Hvert flerdosis hætteglas indeholder 44 mikrogram follitropin alfa* (svarende til 600 IE), så der kan dispenseres 33 mikrogram (svarende til 450 IE) i 0,75 ml .
Each multidose vial contains 44 micrograms of follitropin alfa* (equivalent to 600 IU), in order to deliver 33 micrograms (equivalent to 450 IU) in 0.75 mL.
Hvert flerdosis hætteglas indeholder 44 mikrogram follitropin alfa*, svarende til 600 IE.
Each multidose vial contains 44 micrograms follitropin alfa* equivalent to 600 IU.
Hvert flerdosis hætteglas indeholder 87 mikrogram follitropin alfa* (svarende til 1.200 IE), så der kan dispenseres 77 mikrogram (svarende til 1.050 IE) i 1,75 ml .
Each multidose vial contains 87 micrograms of follitropin alfa* (equivalent to 1200 IU), in order to deliver 77 micrograms (equivalent to 1050 IU) in 1.75 mL.
Hvert Flixabi-hæ tteglas indeholder 100 mg infliximab.
Each Flixabi vial contains 100 mg infliximab.
Hvert følsomt lægemiddel i regimet blev tildelt en score på 1, og lægemidler, hvor ANRS-algoritmen forudsagde resistens, blev tildelt værdien ‘0’.
Each susceptible drug in the regimen received a score of 1 and drugs for which the ANRS algorithm predicts resistance were ascribed the value ‘0’.
Hvert glas indeholder 30 eller 180 tabletter.
Each bottle contains 30 tablets or 180 tablets.
Hvert glas indeholder 500 IE eller 1000 IE human koagulationsfaktor IX.
Each vial contains 500 IU or 1000 IU of human coagulation factor IX.
Hvert glas indeholder enten 270 eller 300 tabletter.
Each bottle contains either 270 or 300 tablets.
Hvert gram af cremen indeholder 115 mg eflornithin (som hydrochloridmonohydrat).
Each gram of cream contains 115 mg eflornithine (as hydrochloride monohydrate).
Hvert gram creme indeholder 115 mg eflornithin (som hydrochloridmonohydrat).
Each gram of cream contains 115 mg of eflornithine (as hydrochloride monohydrate).
Hvert gram crème indeholder 115 mg eflornithin (som hydrochloridmonohydrat).
Each gram of cream contains 115 mg of eflornithine (as hydrochloride monohydrate).
Hvert gram indeholder 10 mg retapamulin (1 % w/w)
Each gram contains 10 mg retapamulin (1% w/w)
Hvert gram Regranex indeholder 100 mikrogram becaplermin
Each gram of Regranex contains 100 micrograms of becaplermin.
Hvert gram salve indeholder 10 mg retapamulin.
Each gram of ointment contains 10 milligrams of retapamulin.
Hvert Holoclar- præparat fremstilles individuelt og er kun beregnet til en enkelt behandling, selvom behandlinger kan gentages.
Each preparation of Holoclar is made individually and is for a single treatment only, although treatments can be repeated.
Hvert huskekort til patienter skal indeholde oplysninger om de følgende hovedpunkter:
The patient card should include information on the following key elements :
Hvert hæ tteglas indeholder 100 mg infliximab.
Each vial contains 100 mg of infliximab.
Hvert hætteglas af 1 ml koncentrat indeholder 20 mg docetaxel.
One vial of 1 ml of concentrate contains 20 mg of docetaxel.
Hvert hætteglas af 4 ml koncentrat indeholder 80 mg docetaxel.
One vial of 4 ml of concentrate contains 80 mg of docetaxel.
Hvert hætteglas af 6 ml koncentrat indeholder 120 mg docetaxel.
One vial of 6 ml of concentrate contains 120 mg of docetaxel.
Hvert hætteglas af 8 ml koncentrat indeholder 160 mg docetaxel.
One vial of 8 ml of concentrate contains 160 mg of docetaxel.
Hvert hætteglas af 9 ml koncentrat indeholder 180 mg docetaxel.
One vial of 9 ml of concentrate contains 180 mg of docetaxel.
Hvert hætteglas aldesleukin (1,3 mg/hætteglas) rekonstitueres under aseptiske forhold med 1,2 ml vand til injektionsvæsker (se produktresuméer for kommercielt tilgængeligt aldesleukin).
Each vial of aldesleukin (1.3 mg / vial) is reconstituted aseptically with 1.2 mL water for injections (see commercially available aldesleukin SmPC).
Hvert hætteglas bør rekonstitueres med 20 ml sterilt vand til injektionsvæsker til engangsbrug, så der opnås en 20 mg/ml opløsning.
Each vial should be reconstituted with 20.0 mL of single-use sterile water for injections to yield a 20 mg/mL solution.
Hvert hætteglas bør rekonstitueres med 5,2 ml sterilt vand til injektionsvæsker til engangsbrug, så der opnås en 20 mg/ml opløsning.
Each vial should be reconstituted with 5.2 mL of single-use sterile water for injections to yield a 20 mg/mL solution.
Hvert hætteglas bør skvulpes forsigtigt for at undgå skumdannelse og sikre, at alt Orbactiv- pulver er helt opløst i koncentratet.
Each vial should be swirled gently to avoid foaming and ensure that all Orbactiv powder is completely reconstituted in solution.
Hvert hætteglas bør skvulpes forsigtigt for at undgå skumdannelse og sikre, at alt pulver er helt opløst i koncentratet.
Each vial should be swirled gently to avoid foaming and ensure that all of the powder is completely reconstituted in solution.
Hvert hætteglas Docefrez 20 mg indeholder 1 ml 35,4 % w/w ethanol i polysorbat 80.
Each solvent vial of Docefrez 20 mg contains 1 ml of 35.4% w/w Ethanol in Polysorbate 80
Hvert hætteglas Docefrez 20 mg indeholder 20 mg docetaxel (vandfri) (plus 22 % overfyldning: 24,4 mg docetaxel).
Each vial of Docefrez 20 mg contains 20 mg docetaxel (anhydrous) (plus 22% overfill: 24.4 mg docetaxel).
Hvert hætteglas Docefrez 80 mg indeholder 4 ml 35,4 % w/w ethanol i polysorbat 80.
Each solvent vial of Docefrez 80 mg contains 4 ml of 35.4% w/w ethanol in Polysorbate 80.
Hvert hætteglas Docetaxel Teva 20 mg/0,72 ml koncentrat indeholder 20 mg docetaxel (vandfri).
Each vial of Docetaxel Teva 20 mg/0.72 ml concentrate contains 20 mg docetaxel (anhydrous).
Hvert hætteglas Enbrel 50 mg indeholder 50 mg etanercept.
Each vial of Enbrel 50 mg contains 50 mg of etanercept.
Hvert hætteglas Enbrel bør kun anvendes én gang til en enkelt patient, og resterende indhold i hætteglasset bør bortkastes.
Each vial should be used for just one dose in one patient, and any remaining solution should be discarded.
Hvert hætteglas Enbrel indeholder 50 mg etanercept.
Each vial of Enbrel contains 50 mg etanercept.
Hvert hætteglas er kun til éngangsbrug.
Each vial is for single use only.
Hvert hætteglas er lukket med en 20 mm bromobutyl gummiprop og en aluminium-plasthætte.
Each container is closed with a 20 mm bromobutyl rubber stopper and a central tear-off aluminium-plastic cap.
Hvert hætteglas er lukket med en latexfri gummiprop og en forsegling af aluminium, og indeholder 5 ml koncentrat (100 mg ofatumumab).
Each glass vial is closed with a latex-free rubber stopper and aluminium over-seal, and contains 5 ml of concentrate (100 mg of ofatumumab).
Hvert hætteglas er lukket med en latexfri gummiprop og en forsegling af aluminium, og indeholder 50 ml koncentrat (1.000 mg ofatumumab).
Each glass vial is closed with a latex-free rubber stopper and aluminium over-seal, and contains 50 ml of concentrate (1,000 mg of ofatumumab).
Hvert hætteglas er til engangsbrug og bør anvendes straks efter anbrud.
Each vial is for single use and should be used immediately after opening.
Hvert hætteglas er til engangsbrug og må kun punkteres én gang.
Each vial is for single use and should only be punctured once.
Hvert hætteglas giver 150 mikrogram/ 0,5 ml opløsning, når det er rekonstitueret som anbefalet.
Each vial provides 150 micrograms/0.5 ml of solution when reconstituted as recommended.
Hvert hætteglas har en beskyttende, brudsikker plastikhætte.
Each vial has a protective, tamper–proof plastic cap.
Hvert hætteglas in-deholder 925-2 770 MBq (svarende til 0,25-0,75 μg kobber-64). (MBq: mega-becquerel, becquerel er enheden for radioaktivitet).
One vial contains from 925 to 2,770 MBq (corresponding to 0.25-0.75 micrograms of copper-64). (MBq: mega Becquerel, Becquerel is the unit in which radioactivity is measured)
Hvert hætteglas indeholder 0,25 mg cetrorelixacetat.
Each vial contains 0.25 mg cetrorelix acetate.
Hvert hætteglas indeholder 0,25 mg trabectedin.
Each vial contains 0.25 mg of trabectedin.
Hvert hætteglas indeholder 0,31 mg sulesomab.
One vial contains 0.31 mg sulesomab
Hvert hætteglas indeholder 0,482 mmol natrium.
Each vial contains 0.482 mmol of sodium.
Hvert hætteglas indeholder 0,56 mg pulver.
0.56 mg of powder.
Hvert hætteglas indeholder 1 g pulver med 3,3 mg eptotermin alfa*.
Each vial contains 3.3 mg of eptotermin alfa
Hvert hætteglas indeholder 1 mg bortezomib (som mannitol- borsyreester).
Each vial contains 1 mg of bortezomib (as a mannitol boronic ester).
Hvert hætteglas indeholder 1 mg topotecan (som hydrochlorid) .
Each vial contains 1 mg topotecan (as hydrochloride).
Hvert hætteglas indeholder 1 mg topotecan (som hydrochlorid) samt 10 % overskud.
Each vial contains 1 mg topotecan (as hydrochloride), with a 10 % overage of fill.
Hvert hætteglas indeholder 1 mg trabectedin.
Each vial contains 1 mg of trabectedin.
Hvert hætteglas indeholder 1 ml af 1 x 106 (1 million) plaquedannende enheder (PFU) af talimogene laherparepvec.
Each vial contains 1 mL of 1 x 106 (1 million) plaque forming units (PFU) of talimogene laherparepvec.
Hvert hætteglas indeholder 1 ml af 1 x 108 (100 millioner) plaquedannende enheder (PFU) af talimogene laherparepvec.
Each vial contains 1 mL of 1 x 108 (100 million) plaque forming units (PFU) of talimogene laherparepvec.
Hvert hætteglas indeholder 1 ml udviklet volumen Imlygic i en nominel koncentration på 1 x 106 (1 million) plaquedannende enheder (PFU)/ml
Each vial contains 1 mL deliverable volume of Imlygic at a nominal concentration of 1 x 106 (1 million) plaque forming units (PFU)/mL
Hvert hætteglas indeholder 1 ml udviklet volumen Imlygic i en nominel koncentration på 1 x 108 (100 millioner) plaquedannende enheder (PFU)/ml
Each vial contains 1 mL deliverable volume of Imlygic at a nominal concentration of 1 x 108 (100 million) plaque forming units (PFU)/mL.
Hvert hætteglas indeholder 1 ml.
Each vial contains 1 ml.
Hvert hætteglas indeholder 1,1 mg thyrotropin alfa.
Each vial contains 1.1 mg thyrotropin alfa.
Hvert hætteglas indeholder 1,5 ml (2 GBq på referencedato) til 3,1 ml (4 GBq på referencedato.) injektionsvæske.
Each vial contains 1.5 ml (2 GBq at reference) to 3.1 ml (4 GBq at reference) of solution for injection.
Hvert hætteglas indeholder 1.000 internatinale enheder humant insulin i 10 ml injektionsvæske, suspension.
Each vial contains 1,000 international units of human insulin in 10 ml suspension for injection.
Hvert hætteglas indeholder 1.000 internationale enheder humant insulin i 10 ml injektionsvæske, suspension.
Each vial contains 1,000 international units of human insulin in 10 ml suspension for injection.
Hvert hætteglas indeholder 1.000 mg ofatumumab i 50 ml.
Each vial contains 1,000 mg of ofatumumab in 50 ml.
Hvert hætteglas indeholder 1.000 mg ofatumumab i 50 ml.
Each vial contains 1,000 mg ofatumumab in 50 ml.
Hvert hætteglas indeholder 1.000 mg pemetrexed (som pemetrexeddinatrium-hemipentahydrat).
Each vial contains 1,000 mg of pemetrexed (as pemetrexed disodium hemipentahydrate).
Hvert hætteglas indeholder 1.000 mg pemetrexed (som pemetrexeddinatriumhemipentahydrat).
Each vial contains 1,000 mg of pemetrexed (as pemetrexed disodium hemipentahydrate).
Hvert hætteglas indeholder 1.200 IE follitropin alfa.
Each vial contains 1,200 IU of follitropin alfa.
Hvert hætteglas indeholder 10 mg basiliximab.
Each vial contains 10 mg basiliximab*.
Hvert hætteglas indeholder 10 mg carfilzomib.
Each vial contains 10 mg of carfilzomib.
Hvert hætteglas indeholder 10 mg cladibrine i 5 ml opløsning.
Each vial contains 10 mg cladribine in 5 ml solution.
Hvert hætteglas indeholder 10 mg cladribine i 5 ml opløsning.
Each vial contains 10 mg of cladribine in 5 ml of solution.
Hvert hætteglas indeholder 10 mg olanzapin.
Each vial contains 10 mg olanzapine.
Hvert hætteglas indeholder 10 ml injektionsvæske, opløsning, svarende til 1000 enheder.
Each vial contains 10 ml of solution for injection, equivalent to 1000 Units.
Hvert hætteglas indeholder 10 ml svarende til 1000 E insulin lispro.
Each container includes 10ml equivalent to 1000U insulin lispro.
Hvert hætteglas indeholder 10 ml svarende til 1000 enheder insulin lispro.
Each container includes 10ml equivalent to 1000 units insulin lispro.
Hvert hætteglas indeholder 10.000 enheder asparaginase*.
Each vial contains 10,000 units of asparaginase*.
Hvert hætteglas indeholder 10.000 enheder asparaginase.
Each vial contains 10,000 units of asparaginase.
Hvert hætteglas indeholder 100 mg anidulafungin (pulver til koncentrat).
Each vial contains 100 mg anidulafungin.
Hvert hætteglas indeholder 100 mg azacitidin.
Each vial contains100 mg azacitidine.
Hvert hætteglas indeholder 100 mg mepolizumab.
Each vial contains 100 mg mepolizumab.
Hvert hætteglas indeholder 100 mg micafungin (som natriumsalt).
Each vial contains: 100 mg micafungin (as sodium).
Hvert hætteglas indeholder 100 mg ofatumumab i 5 ml.
Each vial contains 100 mg of ofatumumab in 5 ml.
Hvert hætteglas indeholder 100 mg palivizumab, som giver 100 mg/ml efter rekonstitution som anbefalet.
Each vial contains: 100 mg palivizumab, providing 100 mg/ml of palivizumab when reconstituted as recommended.
Hvert hætteglas indeholder 100 mg panitumumab.
Each vial contains 100 mg of panitumumab.
Hvert hætteglas indeholder 100 mg pemetrexed (som pemetrexeddinatrium hemipentahydrat).
Each vial contains 100 mg of pemetrexed (as pemetrexed disodium hemipentahydrate).
Hvert hætteglas indeholder 100 mg pemetrexed (som pemetrexeddinatrium).
Each vial contains 100 mg of pemetrexed (as pemetrexed disodium).
Hvert hætteglas indeholder 100 mg pemetrexed (som pemetrexeddinatrium-hemipentahydrat).
Each vial contains 100 mg of pemetrexed (as pemetrexed disodium hemipentahydrate).
Hvert hætteglas indeholder 100 mg temozolomid.
Each vial contains 100 mg of temozolomide.
Hvert hætteglas indeholder 100 mg temozolomid.
Each vial contains 100 mg temozolomide.
Hvert hætteglas indeholder 100 mikrogram darbepoetin alfa i 1 ml (100 µg/ml).
Each vial contains 100 micrograms of darbepoetin alfa in 1 ml (100 µg/ml).
Hvert hætteglas indeholder 100 mikrogram peginterferon alfa-2b målt på proteinbasis.
Each vial contains 100 micrograms of peginterferon alfa-2b as measured on a protein basis.
Hvert hætteglas indeholder 100 mikrogram peginterferon alfa-2b målt på proteinbasis.
Each vial contains 100 micrograms of peginterferon alfa-2b measured on a protein basis.
Hvert hætteglas indeholder 100 mikrogram ziconotid (som acetat).
Each vial contains 100 micrograms ziconotide (as acetate).
Hvert hætteglas indeholder 1000 internationale enheder humant insulin i 10 ml injektionsvæske, opløsning.
Each vial contains 1,000 international units of human insulin in 10 ml solution for injection.
Hvert hætteglas indeholder 1000 mg pemetrexed (som pemetrexeddinatrium).
Each vial contains 1000 mg of pemetrexed (as pemetrexed disodium).